Invention Grant
- Patent Title: Granzyme B directed imaging and therapy
-
Application No.: US16969823Application Date: 2019-02-13
-
Publication No.: US11667645B2Publication Date: 2023-06-06
- Inventor: Geoffrey Malcolm Bilcer , Terence Alfred Kelly
- Applicant: CytoSite Biopharma Inc.
- Applicant Address: US MA Sudbury
- Assignee: CytoSite Biopharma Inc.
- Current Assignee: CytoSite Biopharma Inc.
- Current Assignee Address: US MA Sudbury
- Agency: McDermott Will & Emery LLP
- International Application: PCT/US2019/017802 2019.02.13
- International Announcement: WO2019/160916A 2019.08.22
- Date entered country: 2020-08-13
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K38/06 ; A61K49/04 ; A61K51/04 ; A61P37/00 ; A61P37/02 ; C07K5/08 ; C07D487/06 ; C07D498/06 ; A61B6/03
Abstract:
Provided herein are heterocyclic compounds useful for imaging Granzyme B. Methods of imaging Granzyme B, combination therapies, and kits comprising the Granzyme B imaging agents are also provided.
Public/Granted literature
- US20200369673A1 GRANZYME B DIRECTED IMAGING AND THERAPY Public/Granted day:2020-11-26
Information query
